2Mancia G,Fagard R,Narkiewicz K, et al. 2013ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hyperten- sion of the European Society of Hypertension (ESH)and of the European Society of Cardiology (ESC)[J]. J Hy- peytens, 2013,31 (7) : 1281-1357.
3Ripley TL,Hennebry TA, Sanders TN,et al. Impact of a clinical pharmacist on a cardiovascular surrogate end- point: a pilot study [J]. Pharm Pract (Granada) ,2012,10 (3) : 173-179.
4Nakamura K, Shimizu J, Kataoka N ,et al. Altered nano/micro-order e- lasticity of pulmonary artery smooth muscle cells of patients with idio- pathic pulmonary arterial hypertension [J].Intemational Journal of Carcli- ology, 2010,140(I):102-107.